Delivery Order SPE2DB24D2106-SPE2DB25FATYS

Award Date 10/31/24
Potential Completion Date 11/1/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The firm fixed-price order has a potential value of $3,075.64 and a completion date of February 9, 2024. DMS Pharmaceutical Group holds an Indefinite Delivery Vehicle (IDV) contract, valued up to $4,999,999 through 2025, with DLA for the provision of a broad range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,762.08 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to issue delivery orders for a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,762.08, is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The award has a firm fixed-price pricing type and a completion date of May 2, 2024. This order is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,440.52 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The order is for VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a potential value of $5,762.08 and a completion date of February 5, 2024. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $19,896.90, is for the delivery of 0.5 ML CAPVAXIVE syringes to support the recurring medical supply needs of military healthcare facilities. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the...
This is a $4,321.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business organization. The contract is to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of March 4, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with the Defense Logistics Agency valued up to $4,999,999 through 2025, which enables the agency to issue delivery orders...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $7,202.60 order is for VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a completion date of February 23, 2024. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA, contract SPE2DB valued up to $4,999,999 through 2025, enabling DLA to place delivery orders for a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $8,643.12 firm fixed-price contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.S0ML, with a completion date of February 22, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which enables DLA to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.0.5 ML, with a completion date of March 6, 2024 and a potential value of $4,321.56. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. This...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB25FATYS
    Delivery Order

This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) for the supply of 0.5 mL prefilled syringes of the pneumococcal vaccine VAXNEUVANCE. The $13,978.95 delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military healthcare facilities. The delivery order does not have any set-aside designation. The contract has an ultimate completion date of November 1, 2024.

Generated 1/30/25, 9:18 AM